Relevant studies have shown that S100A16 can reduce the sensitivity of 3T3-L1 to insulin, overexpression of S100A16 can promote lipid synthesis of 3T3-L1 preadipocytes, inhibiting glucose uptake under insulin stimulation, and cause insulin resistance (Kan et al., 2019). The gene discussed is INS; the disease is Insulin resistance.